UBS Group
CDMO

UBS Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

UBS Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-571
Closed -$6K – 9488
2014
Q4 		$6K Buy
+571
New +$5.75K ﹤0.01% 8866

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's CDMO Position: Q1 2025 in Review

UBS Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 794,861 shares — an estimated $9.82M sold.

UBS Group first reported a position in CDMO in Q4 2014 and held it in 40 quarters. The position peaked at $9.82M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • UBS Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • UBS Group sold 794,861 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $9.82M.
  • UBS Group first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2014 and held it in 40 quarters.
  • UBS Group's Avid Bioservices, Inc. Common Stock position peaked at $9.82M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.